Insulin Micropump with Embedded Pressure Sensors for Failure Detection and Delivery of Accurate Monitoring

被引:26
作者
Dumont-Fillon, Dimitry [1 ]
Tahriou, Hassen [1 ]
Conan, Christophe [1 ]
Chappel, Eric [1 ]
机构
[1] Debiotech SA, CH-1004 Lausanne, Switzerland
关键词
MEMS; micropump; piezoresistive pressure sensor; failure detection; insulin delivery; INFUSION; INJECTIONS;
D O I
10.3390/mi5041161
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Improved glycemic control with insulin pump therapy in patients with type 1 diabetes mellitus has shown gradual reductions in nephropathy and retinopathy. More recently, the emerging concept of the artificial pancreas, comprising an insulin pump coupled to a continuous glucose meter and a control algorithm, would become the next major breakthrough in diabetes care. The patient safety and the efficiency of the therapy are directly derived from the delivery accuracy of rapid-acting insulin. For this purpose, a specific precision-oriented design of micropump has been built. The device, made of a stack of three silicon wafers, comprises two check valves and a pumping membrane that is actuated against stop limiters by a piezo actuator. Two membranes comprising piezoresistive strain gauges have been implemented to measure the pressure in the pumping chamber and at the outlet of the pump. Their high sensitivity makes possible the monitoring of the pumping accuracy with a tolerance of +/- 5% for each individual stroke of 200 nL. The capability of these sensors to monitor priming, reservoir overpressure, reservoir emptying, outlet occlusion and valve leakage has also been studied.
引用
收藏
页码:1161 / 1172
页数:12
相关论文
共 13 条
[1]  
Borot Sophie, 2014, J Diabetes Sci Technol, V8, P1133, DOI 10.1177/1932296814543946
[2]  
Chappel E., 2014, P 12 MICR BIOMES MED
[3]  
Chappel E., 2011, P 25 EUR C ATH GREEC
[4]   A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine [J].
Doyle, EA ;
Weinzimer, SA ;
Steffen, AT ;
Ahern, JAH ;
Vincent, M ;
Tamborlane, WV .
DIABETES CARE, 2004, 27 (07) :1554-1558
[5]   Design of an implantable active microport system for patient specific drug release [J].
Geipel, A. ;
Goldschmidtboeing, F. ;
Jantscheff, P. ;
Esser, N. ;
Massing, U. ;
Woias, P. .
BIOMEDICAL MICRODEVICES, 2008, 10 (04) :469-478
[6]   Continuous subcutaneous insulin infusion (CSII)of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII [J].
Hirsch, IB ;
Bode, BW ;
Garg, S ;
Lane, WS ;
Süssman, A ;
Hu, P ;
Santiago, OM ;
Kolaczynski, J .
DIABETES CARE, 2005, 28 (03) :533-538
[7]  
International Electrotechnical Commission, 1998, IEC60601224
[8]   Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis [J].
Jeitler, K. ;
Horvath, K. ;
Berghold, A. ;
Gratzer, T. W. ;
Neeser, K. ;
Pieber, T. R. ;
Siebenhofer, A. .
DIABETOLOGIA, 2008, 51 (06) :941-951
[9]   A review of micropumps [J].
Laser, DJ ;
Santiago, JG .
JOURNAL OF MICROMECHANICS AND MICROENGINEERING, 2004, 14 (06) :R35-R64
[10]   Compact, power-efficient architectures using microvalves and microsensors, for intrathecal, insulin, and other drug delivery systems [J].
Li, Tao ;
Evans, Allan T. ;
Chiravuri, Srinivas ;
Gianchandani, Roma Y. ;
Gianchandani, Yogesh B. .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (14) :1639-1649